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Within Streptococcus suis serotype 2, pathogenic, weakly pathogenic, and nonpathogenic strains can be found.
We introduced a genomic library of a pathogenic strain into a weakly pathogenic strain. After infection of the
library into young piglets pathogenic transformants were selected. One specific transformant containing a 3-kb
fragment of the pathogenic strain appeared to be dominantly enriched in diseased pigs. The observed enrich-
ment was not tissue specific. The selected fragment, when introduced into two different weakly pathogenic
strains, increased the virulence of these strains considerably. In contrast, introduction of the corresponding
fragment of a weakly pathogenic strain had only minor effects on virulence. Nucleotide sequence analysis of the
selected fragment of the pathogenic strain revealed the presence of two potential open reading frames, both of
which were found to be mutated in the corresponding fragment of the weakly pathogenic strain. These data
strongly suggest that the selected fragment contains determinants important for virulence.
Streptococcus suis is an important cause of meningitis, sep-
ticemia, arthritis, and sudden death in young pigs (6, 32). It can
also cause meningitis in humans (1). Attempts to control the
disease are still hampered by the lack of sufficient knowledge
about the pathogenesis of the disease and the lack of effective
vaccines and sensitive diagnostic methods.
So far, 35 serotypes of S. suis have been described (8–10).
Virulence of S. suis can differ within and among serotypes (30,
31, 33, 34). Worldwide, S. suis serotype 2 is the most frequently
isolated serotype. Within S. suis serotype 2, pathogenic, weakly
pathogenic, and nonpathogenic strains can be found (33, 34).
The pathogenic strains cause severe clinical signs of disease in
pigs, and large numbers of bacteria can be reisolated from the
central nervous system (CNS) and the joints after experimental
infection (33, 34). The weakly pathogenic strains cause only
mild clinical signs of disease, and only infrequently can bac-
teria be reisolated from the CNS and the joints after exper-
imental infection (33, 34). The nonpathogenic strains are com-
pletely avirulent in young pigs after experimental infection (33,
34).
The 136-kDa muramidase-related protein and the 110-kDa
extracellular factor are generally considered important viru-
lence markers for S. suis serotype 2 strains isolated in Europe
and the United States (2, 7, 17, 22, 29, 36). However, differ-
ences in virulence between pathogenic, weakly pathogenic, and
nonpathogenic strains cannot be explained exclusively by dif-
ferences in their muramidase-related protein and extracellular
factor expression patterns (27). In addition, it is known that the
capsule of S. suis serotype 2 is an important virulence factor
(24). However, since both pathogenic, weakly pathogenic, and
nonpathogenic strains seem to be fully encapsulated after
growth in vitro and in vivo (H. E. Smith and H. J. Wisselink,
unpublished data), it is not likely that the level of encapsula-
tion of these strains is associated with the difference in viru-
lence. To gain insight into the differences between pathogenic,
weakly pathogenic, and nonpathogenic strains that determine
the differences in virulence, we applied an in vivo complemen-
tation system.
It was previously shown, by ribotyping and random amplified
polymorphic DNA analysis assays, that pathogenic and weakly
pathogenic strains of S. suis serotype 2 are genetically closely
related, whereas nonpathogenic strains showed a high degree
of genetic heterogeneity (4, 25). Therefore, we envisaged the
possibility that the introduction of DNA fragments of a patho-
genic strain into a weakly pathogenic strain could increase
its virulence. To challenge this hypothesis we constructed a
genomic library of the pathogenic S. suis strain 10 in a plasmid
and introduced the plasmid library into the weakly pathogenic
reference strain of S. suis serotype 2, strain S735 (35). Pigs
were inoculated intravenously with the recombinants, and bac-
teria were recovered from the CNS and the joints of diseased
pigs. The reisolated bacteria were subsequently analyzed for
their plasmid content and virulence.
Complementation system. A genomic library of the patho-
genic S. suis strain 10 (34) was constructed into the weakly
pathogenic strain S735 (35). To do this, we used the plasmid
pCOM1 (Fig. 1). pCOM1 is based on the replication functions
of pWVO1 (13), which functions in Escherichia coli as well as
in S. suis (28). Moreover, the vector contained the erythromy-
cin resistance gene of pE194 (11) preceded by the promoter
region of the mrp gene (26) as well as the SacI-PstI part of the
multiple cloning site of pKUN19 (14). Sau3AI partial digests
(23) of the DNA of the pathogenic S. suis serotype 2 strain 10
were size fractionated (.3 kb) by precipitation with 4.6% of
polyethylene glycol 6000 (BDH Chemicals) (20). The frag-
ments were ligated to BamHI-digested pCOM1 (Fig. 1), and
the ligation mixtures were transformed into E. coli XL2-blue
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cells (Stratagene). Erythromycin-resistant colonies were se-
lected on Luria broth (19) containing 1.5% (wt/vol) agar and
200 mg of erythromycin per ml. About 17,000 independent E.
coli clones were obtained. Analysis of 55 of the transformants
showed that 64% contained an insert of .3 kb (results not
shown). From the pool of E. coli transformants, plasmid DNA
was isolated and was subsequently used for the electrotrans-
formation of the weakly pathogenic S. suis strain S735 (28). S.
suis transformants were selected on Columbia agar blood base
(code CM331; Oxoid) plates containing 6% (vol/vol) horse
blood and 1 mg of erythromycin per ml. This resulted in ap-
proximately 30,000 independent S. suis transformants. The S.
suis library was designated S735(pCOM-L). As determined by
analysis of 24 randomly selected transformants, more than
30% of the S735(pCOM-L) transformants contained an insert
of .3 kb (results not shown). The transformants were pooled
and stored at 280°C.
Selection of genomic fragments associated with virulence.
To select for genetic determinants of the pathogenic S. suis
strain 10 that could increase the virulence of the weakly patho-
genic strain S735, 1-week-old pigs were inoculated intrave-
nously with the S. suis library S735(pCOM-L) as described
before (31, 34). We used a dose of either 107 or 108 CFU, and
the pigs received erythromycin twice a day orally (erythromy-
cin stearate, 40 mg/kg of body weight; Abbott B.V., Am-
stelveen, The Netherlands). Two hours after the infection, the
pigs were treated with erythromycin for the first time. To score
disease, we measured the body temperature of the pigs, the
number of polymorphonuclear leukocytes in blood, and clini-
cal signs of disease such as signs of nervousness and lameness.
Moreover, to monitor infection with S. suis we collected swabs
of the nasopharynx and feces daily. The swabs were plated
directly onto Columbia agar containing 6% horse blood. After
the pigs were killed, they were examined for pathological
changes. Moreover, tissue specimens were collected from the
CNS, serosae, joints, lungs, liver, kidneys, spleen, heart, and
tonsils. The tissues were homogenized in the presence of
Todd-Hewitt medium (code CM189; Oxoid) by using an Ultra-
Turrax tissuemizer (Omni International, Waterbury, Conn.)
and were centrifuged for 5 min at 1,200 3 g, and the superna-
tants were plated onto Columbia agar containing 6% horse
blood.
All pigs showed specific S. suis symptoms (Table 1) 3 to 7
days after the infection, and except for one, all pigs died during
the course of the experiment. From five of the pigs bacteria
could be reisolated from the CNS, and from two other pigs
bacteria were isolated from the joints (Table 1). In previous
experiments in which pigs were inoculated with weakly patho-
genic strains, specific S. suis symptoms were observed at a very
FIG. 1. pCOM1 vector used in this study. pCOM1 contains the
replication functions of pWVO1 (Ori) (13) and the erythromycin re-
sistance gene (ery) of pE194 (11) preceded by the promoter region of
the mrp gene (Pmrp) (26) as well as the SacI-PstI part of the multiple
cloning site of pKUN19 (14).
TABLE 1. Virulence of S. suis library and strains in germfree pigs
Strain No. ofpigs
Dose of
S. suis
(CFU)
Mortalitya
(%)
Mean no. of
days until
death
Morbidityb
(%)
Clinical index of
the group Fever
indexe
Leukocyte
index f
No. of pigs in which
S. suis was iso-
lated from:
Specificc
symptoms
Nonspecificd
symptoms CNS Serosae Joints
S735(pCOM-L) 4 107 100 4 100 69 91 25 NAg 3 2 3
4 108 75 7 100 50 69 20 17 2 1 2
S735(pCOM-V10) 5 106 100 1 100 100 100 54 4 5 5 5
S735(pCOM1) 4 106 25 12 25 2 11 6 80 1 1 2
S735(pCOM-V10) 5 106 100 1 100 100 100 60 NA 5 5 5
S735(pCOM-V735) 5 106 20 15 100 40 26 17 52 1 1 1
S735(pCOM1) 5 106 20 16 60 11 9 11 20 1 0 0
24(pCOM-V10) 5 106 100 2 100 50 66 42 29 3 3 5
24(pCOM-V735) 4 106 25 15 100 40 30 17 18 1 0 0
24(pCOM1) 5 106 20 15 20 2 14 6 21 1 0 0
a Percentage of pigs that died due to infection or had to be killed for animal welfare reasons.
b Percentage of pigs with specific symptoms.
c Percentage of observations for the experimental group in which specific symptoms (ataxia, lameness of at least one joint, and/or stillness) were observed.
d Percentage of observations for the experimental group in which nonspecific symptoms (loss of appetite and/or depression) were observed.
e Percentage of observations for the experimental group of a body temperature of .40°C.
f Percentage of blood samples for the experimental group in which the concentration of granulocytes was .1010/liter.
g NA, not applicable.
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low frequency (34, 35). In addition, from those pigs, bacteria
could never be reisolated from the CNS or from the joints.
Therefore, these data indicate that, compared to the viru-
lence of strain S735, bacteria isolated from pigs inoculated with
the S. suis library S735(pCOM-L) are more virulent due to the
presence of a DNA fragment of the pathogenic strain 10. The
plasmid content of 90 randomly selected clones isolated from
the CNS or the joints of the seven diseased pigs was analyzed
by PCR and restriction analysis. The results showed that 88 of
the 90 clones analyzed (19 of which are shown in Fig. 2)
contained an insert of about 3 kb and had identical restriction
patterns. Moreover, the inserts of 10 randomly selected clones
having identical restriction patterns also showed identical
DNA sequences (results not shown). Plasmid DNA of 10 ran-
domly selected clones from the original S735(pCOM-L) library
showed 10 different restriction patterns (Fig. 2). These data
suggest that one specific clone, which was designated S735
(pCOM-V10), was greatly enriched in seven different pigs.
Moreover, this particular clone was isolated from the CNS as
well as from the joints of the various pigs, indicating that the
observed enrichment was not tissue specific.
Virulence-associated properties of the selected fragment,
V10. To further analyze the virulence properties of strain S735
(pCOM-V10), pigs were inoculated intravenously with 106
CFU of strain S735(pCOM1) or strain S735(pCOM-V10). The
results (Table 1) clearly show that, compared to the virulence
of strain S735(pCOM1), the virulence of strain S735(pCOM-
V10) was greatly enhanced. All pigs inoculated with strain S735
(pCOM-V10) showed specific S. suis symptoms and died within
1 day of infection. In contrast, except for one, none of the pigs
inoculated with the control strain S735(pCOM1) showed spe-
cific clinical symptoms, and these pigs survived until the end of
the experiment (15 days after infection). These data proved
that the introduction of fragment V10 of strain 10 into S735
transformed the weakly pathogenic strain S735 into a highly
pathogenic strain. This strongly suggests that the protein(s) en-
coded by V10 is an important virulence determinant and plays
an important role in the pathogenesis of S. suis serotype 2
infections in pigs.
To find out whether the observed increase of virulence by
fragment V10 was specific for strain S735, we introduced
pCOM1 and pCOM-V10 into another weakly pathogenic
strain, strain 24 (34). Subsequently, we determined the vir-
ulence properties of the strains 24(pCOM1) and 24(pCOM-
V10). As shown in Table 1, similar effects of V10 on the vir-
ulence of strains S735 and 24 were observed. Both strains 24
(pCOM-V10) and S735(pCOM-V10) were highly pathogenic for
young piglets, whereas strains 24(pCOM1) and S735(pCOM1)
were shown to be only weakly pathogenic (Table 1). This strong-
ly indicates that V10 has a more general ability to transform
weakly pathogenic serotype 2 strains into highly pathogenic
strains.
Because we used a plasmid system for the complementa-
tion approach, gene-dose effects cannot be excluded. Plasmid
pCOM1 is based on the replication functions of pWVO1. In
gram-positive bacteria the latter plasmid has a copy number
between 3 and 6 (13). To find out whether copy number effects
play a role, we cloned the genomic region of strain S735 ho-
mologous to fragment V10 of strain 10 (see below) into plas-
mid pCOM1. This plasmid was designated pCOM-V735. The
virulence of strains S735(pCOM-V735) and 24(pCOM-V735)
was subsequently compared to that of S735(pCOM-V10), S735
(pCOM1), 24(pCOM-V10), and 24(pCOM1). The results (Ta-
ble 1) clearly show that, in contrast to pCOM-V10, the plasmid
pCOM-V735 did not carry virulence-enhancing activity. Pigs
infected with strains S735(pCOM-V10) and 24(pCOM-V10)
died within 1 or 2 days after infection, whereas most of the pigs
infected with strains S735(pCOM-V735), 24(pCOM-V735),
S735(pCOM1), and 24(pCOM1) survived until the end of the
experiment (17 days after infection). Compared to pigs infect-
ed with strains containing pCOM1, pigs infected with strains
containing pCOM-V735 developed more general and specific
signs of disease, but much less so than pigs infected with strains
containing pCOM-V10 (Table 1). From these data we conclud-
ed that the differences in virulence observed between the strains
containing pCOM-V10 and the strains containing pCOM-
V735 are caused by differences between the fragments V10 and
V735 (see below). The differences in virulence observed be-
tween the strains containing pCOM1 and the strains containing
pCOM-VS735 may be due to gene-dose effects.
In previous experiments it was found that pigs infected with
weakly pathogenic strains showed only mild clinical signs of
disease and that bacteria could never be reisolated from the
CNS or the joints (34, 35). Surprisingly, in the experiments
described in this paper, in which we used weakly pathogenic
strains containing the control plasmid pCOM1, bacteria could
(with a low frequency) be reisolated from the CNS as well as
from the joints. There are several possible explanations for
these observed differences. One explanation is that the pres-
ence of the plasmid somehow affects the virulence properties
of the strains. Another possibility is that the treatment of the
pigs with erythromycin makes the pigs more sensitive to S. suis
infections, and a third possibility is that compared to the pigs
used previously, the pigs used for the current experiments were
more sensitive to S. suis infections.
Previously, Charland and coworkers (5) tested the virulence
of strain S735-SM in SPF piglets. In these experiments they
showed that animals infected with strain S735-SM had signs of
meningitis and arthritis. These data did not seem to be in ac-
cord with our data concerning the virulence of strain S735.
However, strain S735-SM is a streptomycin-resistant variant of
strain S735 that was selected by serial passages of strain S735
on broth containing increasing concentrations of streptomycin.
In their experiments the authors did not compare the virulence
FIG. 2. Plasmids digested with SmaI and XbaI on a 0.8% agarose
gel. Library, plasmids isolated from 10 randomly selected clones of the
original library; clones enriched in pigs, plasmids isolated from 19
independently selected clones enriched in pigs; c, pCOM1; m, molec-
ular size marker.
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of strain S735-SM to that of the original S735 strain. Moreover,
the animal model used by these authors differed considerably
from the model used in our experiments. Charland and co-
workers (5) used 6- to 7-week-old specific-pathogen-free
piglets that were infected intravenously with 108 CFU of S.
suis, whereas we used 1-week-old germfree piglets that were
infected intravenously with 106 CFU. These differences will
probably explain the different results obtained.
Sequence analysis of fragments V10 and V735. Large differ-
ences were observed between the effects of the selected frag-
ment, V10, of the pathogenic strain 10 and the corresponding
fragment, V735, isolated from the weakly pathogenic strain
S735, on virulence. In contrast to V10, which had a strong
virulence-enhancing effect on weakly pathogenic strains, V735
showed only minor effects. Therefore, differences between
these two fragments should be responsible for the observed
differences in virulence. To analyze the differences between
fragments V10 and V735, we cloned fragment V735 and
determined the nucleotide sequences of fragments V10 and
V735. A 3.1-kb PstI-HindIII fragment of strain S735 (V735)
was identified by using the fragment V10 as a probe, and this
fragment was subsequently cloned into pCOM1 (Fig. 3). DNA
sequences were determined with a 373A DNA Sequencing
System (Applied Biosystems, Warrington, United Kingdom),
and samples were prepared by use of an ABI/PRISM dye-
terminator cycle-sequencing ready reaction kit (Applied Bio-
systems). The sequence of V10 revealed two complete and two
incomplete open reading frames (ORFs) (Fig. 3). ORF 1 (nu-
cleotides 1 to 461) codes for a polypeptide of 153 amino acids.
This protein shows homology (49% identity) to the C-terminal
region of acetate kinase of Clostridium thermocellum (acces-
sion number AF041841) and various other bacterial species
(12). ORF 2 (nucleotides 625 to 1327) codes for a protein of
233 amino acids. No significant similarities were found be-
tween the predicted amino acid sequence of this protein and
proteins present in the data libraries. ORF 3 (nucleotides 1382
to 2639) codes for a protein of 418 amino acids. This protein
shows homology (36% identity) to folylpolyglutamate syn-
thetase (FolC) of Bacillus subtilis (16, 18). Compared to the
other ORFs, ORF 4 is transcribed in the opposite direction.
ORF 4 (nucleotides 2684 to 2972) codes for a polypeptide of
96 amino acids. This polypeptide shows homology (67% iden-
tity) to the C-terminal part of glutamyl aminopeptidase (PepA)
of Lactococcus lactis (15). ORFs 2 and 3 both possess putative
initiation codons and ribosome-binding sites. Putative 235
(TGGACA) and 210 (TACAAT) sequences, which may func-
tion as promoter sequences, were found preceding ORF 2.
ORFs 2 and 3 are separated by 55 nucleotides. In this region
no putative promoter sequences could be observed. This could
indicate that ORFs 2 and 3 are cotranscribed. Downstream of
ORFs 1 and 3 we found regions of extended dyad symmetry,
which probably function as transcription termination signals.
The sequence of fragment V735 was determined and com-
pared to the sequence of fragment V10. No major deletions or
insertions were found between the sequenced regions. ORFs 1,
3, and 4 of strains 10 and S735 were highly homologous. The
putative protein fragments encoded by the ORF 1’s differ in
two (1.3%) amino acids, whereas the putative protein frag-
ments of the ORF 4’s are identical. The putative proteins
encoded by the ORF 3’s are highly homologous and differ in
only 19 (4.5%) amino acids (Fig. 4B). The proteins encoded
by the ORF 3’s show homology to FolC of various pro- and
eucaryotic organisms. FolC catalyzes the conversion of folates
to polyglutamate derivatives (3). Bacteria require folates for
the biosynthesis of glycine, methionine, formylmethionine, thy-
midine, purines, and pantothenate (3). Whether the FolC pro-
teins encoded by fragments V10 and V735 have different en-
zymatic activities or different substrate specificities is unknown
so far. In E. coli, a folC mutant is methionine deficient (3);
however, so far a role of FolC in virulence has not been de-
scribed.
Major differences were observed between the ORF 2’s of
strains 10 and S735. In the pathogenic strain 10 an ORF of 699
bases was found, predicting a protein product of 233 amino
acids. In contrast, due to a frameshift mutation, in the weakly
pathogenic strain S735 an ORF of 569 bases, coding for a
polypeptide of 183 amino acids, was found. Compared to the
putative protein encoded by strain 10, the putative protein
encoded by strain S735 lacks the N-terminal 50 amino acids
(Fig. 4A). In strain S735 a strong ribosome-binding site pre-
FIG. 3. Schematic representation of fragments V10 and V735. The arrows indicate the potential ORFs. P, position of the potential promoter
sequence; E, positions of the potential transcription regulator sequences. Homologies (% identities) between the potential proteins encoded by
the ORFs and proteins present in the data libraries are indicated.
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cedes the methionine start codon of ORF 2. In contrast, how-
ever, in strain 10 the sequence did not indicate the presence of
a strong ribosome-binding site preceding the methionine start
codon of ORF 2. Therefore, although ORF 2 of strain 10 is
extended compared to ORF 2 of strain S735, it is not clear
whether the proteins expressed by these two ORFs differ in
length. Future experiments will be required to analyze the
expressed proteins in detail. Besides these N-terminal differ-
ences, the putative proteins differ at nine amino acid positions
(4.9%). Except for one, these amino acid substitutions are
clustered at two different positions in the putative protein. The
function of the ORF 2 protein is unknown so far. No homol-
ogies were found between the ORF 2 protein sequences and
protein sequences present in the data libraries. Hydrophobicity
profiles showed that the ORF 2-encoded proteins are very
hydrophobic. A role of the ORF 2 protein in the cellular
membrane is therefore suggested. In addition, the putative
235 regions that may be part of the promoter sequences in-
volved in the expression of ORFs 2 and 3 differed between the
two strains. A TGGACA sequence was found in strain 10,
whereas a TGGTCA sequence was found in strain S735. The
sequence data suggest that the differences in the virulence-
enhancing effects of fragments V10 and V735 may be the
results of functional differences between the putative proteins
expressed by ORFs 2 and/or 3 and/or by differences in their
levels of expression.
In the present paper we describe the development and the
successful application of an in vivo complementation approach
for the identification of important molecular determinants that
determine the differences in virulence between pathogenic and
weakly pathogenic strains of S. suis serotype 2. The strategy
to identify genetic determinants by in vivo complementation
requires two genetically related strains which can be distin-
guished by their ability to cause disease as well as a gene trans-
fer system. Therefore, it is likely that the system is more
generally applicable for the identification of virulence de-
terminants in various bacterial species. Previously, a similar
approach was used to identify virulence genes in Mycobac-
terium tuberculosis (21). A major difference between the two
systems is that the M. tuberculosis virulence genes were se-
lected by using a mouse model. In contrast, we used the nat-
ural host (pigs). Moreover, in the system described for M. tu-
berculosis an integrating cosmid vector was used to introduce
the virulence genes instead of the plasmid system that was used
here.
FIG. 4. Homology between ORFs 2 (A) and 3 (B) encoding proteins of fragments V10 and V735. Asterisks indicate nonidentical amino acids.
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Nucleotide sequence accession numbers. The nucleotide se-
quences for fragments V10 and V735 have been deposited into
the National Center for Biotechnology Information under ac-
cession numbers AF306940 and AF306941, respectively.
We thank D. Mevius for helpful discussions concerning the treat-
ments of the pigs with erythromycin.
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